מיקמין 50 מ"ג - Mycamine 50 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | J02AX Other antimycotics for systemic use | ||||||||||||||||||||||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||||||||
| צ×רת ××ª× | ת××-×ר××× - I.V | ||||||||||||||||||||||||
| צ×רת ××× ×× | ×××§× ×××× ×ª ת×××¡× ×××× ×¤××××, POWDER FOR SOLUTION FOR INFUSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||||||||
| ×ת×××× | Adults, adolescents ⥠16 years of age and elderly:- Treatment of invasive candidiasis.- Treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.Children (including neonates) and adolescents < 16 years of age:- Treatment of invasive candidiasis.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.The decision to use Mycamine should take into account a potential risk for the development of liver. Mycamine should therefore only be used if other antifungals are not appropriate.
| ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××§××× 50 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ASTELLAS IRELAND CO. LTD, IRELAND |
| ×©× ××¢× ×ר×ש×× | ASTELLAS PHARMA INTERNATIONAL B.V., ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 02/2015. ר×ש××× ×ת×ר××: 05/2016 |
| ת×ר×× ×¢×××× ××ר×× | 22/06/2024 |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־22 ביוני 2024 ב־06:51